Skip to main content

Table 1 Haplotype combination distribution among patients and controls

From: Association of CAPN10 haplotype combinations with type 2 diabetes mellitus and metabolic syndrome among Egyptians: pilot study—genotyping of three CAPN10 variants

Haplotype or diplotype

T2DM

Controls

X2

P

OR (95% CI)

Freq

%

Freq

%

111/111

9

18.4

11

20.8

0.092

0.764

0.86 (0.3–2.5)

111/112

8

16.3

1

1.9

6.599

0.011*

10.15 (1.2–225)*

111/121

10

20.4

11

20.8

0.002

0.980

0.98 (0.3–2.8)

111/122

4

8.2

6

11.3

0.287

0.612

0.7 (0.2–3.1)

111/221

4

8.2

7

13.2

0.673

0.430

0.58 (0.1–2.4)

111/222

1

2

3

5.7

0.885

0.361

0.4 (0.01–3.96)

112/112

1

2

1

1.9

0.003

0.980

1.08 (0.0–40.9)

112/122

0

0

2

3.8

1.886

0.177

0.0 (0.0–4.5)

121/121

5

10.2

10

18.9

1.524

0.220

0.49 (0.1–1.7)

121/221

3

6.1

1

1.9

1.212

0.275

3.39 (0.3–87.7)

  1. Bold indicates statistical significant result
  2. *Significant value at P < 0.05